Sandra Pavey

Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)

Jonathan R. Dry, Sandra Pavey, Christine A. Pratilas et al. · Cancer Research · 2010 · 261 citations · Full text

Cell Subsets, Tumor Biology, Transcriptional Regulation +17

Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS

Wieke Zuidervaart, Frans van Nieuwpoort, Mitchell Stark et al. · British Journal of Cancer · 2005 · 214 citations · Full text

Microarray expression profiling in melanoma reveals a BRAF mutation signature

Sandra Pavey, Peter A. Johansson, Leisl Packer et al. · Oncogene · 2004 · 182 citations

Microarray Expression, Functional Genomics, Medicine +10

Nuclear PTEN expression and clinicopathologic features in a population‐based series of primary cutaneous melanoma

David C. Whiteman, Xiaoping Zhou, Margaret C. Cummings et al. · International Journal of Cancer · 2002 · 181 citations · Full text

Up-Regulation of p21WAF1/CIP1 by Histone Deacetylase Inhibitors Reduces Their Cytotoxicity

Andrew Burgess, Sandra Pavey, Robyn Warrener et al. · Molecular Pharmacology · 2001 · 136 citations